Dilevetam-I 100mg/ml Infusion
Marketer
Syntonic Lifesciences
Salt Composition
Levetiracetam (100mg/ml)
Overview Dilevetam-I 100mg/ml Infusion
Levetiracetam 100mg/ml intravenous infusion is an anticonvulsant medication indicated for managing epileptic seizures. It's administered intravenously, under medical supervision, as a slow infusion, and may be used alone or in conjunction with other therapies. Primarily for short-term seizure control when oral administration is impractical (e.g., unconsciousness), its efficacy depends on continuous use as directed by your physician. Long-term seizure management typically transitions to oral medication post-infusion. Common adverse reactions include drowsiness, headache, infection, injection site irritation, upper respiratory tract infection, aggression, and decreased appetite. Behavioral changes, including irritability and agitation, may also occur, often diminishing after initial treatment. While most side effects are mild and self-limiting, serious reactions such as allergic responses (urticaria, pruritus, weakness, dyspnea, facial/lingual/pharyngeal edema), skin rashes, or persistent behavioral alterations (confusion, memory impairment, irritability, heightened aggression) necessitate immediate medical attention. Suicidal ideation has been reported; consult your physician if mood deteriorates. Pre-treatment disclosure of renal impairment, depression, suicidal tendencies, pregnancy, or pregnancy intentions is crucial. Alcohol consumption should be avoided due to increased seizure risk and exacerbated side effects like somnolence and vertigo. Impaired alertness from drowsiness and dizziness may compromise driving or operating machinery. Regular kidney function monitoring may be necessary during treatment.
Primary Ingredients of Dilevetam-I 100mg/ml Infusion
No information provided. Please provide the text you wish to be rewritten.
Uses of Dilevetam-I 100mg/ml Infusion
Managing Epileptic Seizures
Major Benefits of Dilevetam-I 100mg/ml Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Dilevetam-I 100mg/ml Infusion:
- Sleepiness
- Dizziness
- Decreased appetite
- Fatigue
- Headache
- Behavioral changes
- Irritation
- Aggressive behavior
- Agitation
- Infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
How to use Dilevetam-I 100mg/ml Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Dilevetam-I 100mg/ml Infusion works:
Dilevetam-I 100mg/ml infusion is an anticonvulsant drug that targets specific receptors (SV2A) located on neuronal membranes. This binding action inhibits excessive neuronal firing in the brain, thereby preventing the propagation of seizure-inducing electrical impulses.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Dilevetam-I 100mg/ml Infusion is unsafe.
PregnancyCONSULT YOUR DOCTOR
Using Dilevetam-I 100mg/ml Infusion during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Dilevetam-I 100mg/ml infusion during lactation is likely safe. Preliminary data from human studies indicate minimal infant risk. Postnatal monitoring should include observation for somnolence and appropriate weight increase.
DrivingUNSAFE
Administering Dilevetam-I 100mg/ml Infusion may induce drowsiness, visual disturbances, and dizziness. Driving is prohibited if such effects manifest.
KidneyCAUTION
Renal impairment necessitates careful administration of Dilevetam-I 100mg/ml Infusion. Dosage modification for Dilevetam-I 100mg/ml Infusion may be required. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The intravenous administration of Dilevetam-I 100mg/ml is likely safe for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended. A reduced dosage might be considered for those experiencing severe liver dysfunction.
What if you forget to take Dilevetam-I 100mg/ml Infusion :
For omitted Dilevetam-I 100mg/ml Infusion, administer the injection promptly. If your next scheduled dose is imminent, however, forego the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Dilevetam-I 100mg/ml Infusion
| Label | Value |
|---|---|
| Chemical Type | Pyrrolidinone-Acetamide Derivative |
| Developing Habits | No. |
| Type of Treatment | Neuroscience of the Central Nervous System |
| Actions | AED: A protein ligand within synaptic vesicle 2 |
3,018 People bought this recently